ArticleFrontiers in neurology2025

Targeting the gut to improve seizure control in CDKL5 deficiency disorder (CDD): study protocol for a single-arm, open-label clinical trial.

Francesca Triva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.